Emerging Histone PTMs: Identification of Novel Marks and Their Functional Implications

Post-translational modifications (PTMs) represent a fundamental epigenetic mechanism. While initial research centered on classical marks like acetylation and methylation, recent advances rapidly expand this landscape.

Innovations in mass spectrometry and deeper epigenetic investigation have led to the discovery of novel histone marks. These include lysine succinylation, malonylation, crotonylation, and 2-hydroxyisobutyrylation.

These recently identified PTMs significantly enhance the complexity of the "histone code." Furthermore, they exhibit distinct roles in regulating gene expression, cellular metabolism, and disease pathogenesis. Their emergence provides a critical new perspective for comprehending intricate epigenetic networks.

Key Technological Advancements Driving Discovery

Traditional antibody-based methods face significant limitations in detecting new modifications. Issues with specificity and inability to perform simultaneous analysis created major research bottlenecks. Modern mass spectrometry (MS) has overcome these barriers through:

Comparison of in-gel digestion methods for MS-based histone PTM analysis (Noberini R et al., 2021)

Optimized Sample Preparation Strategies

Advances in chemical labeling and enzymatic digestion have been pivotal. Integrating chemical tags with trypsin treatment generates peptides ideally suited for MS analysis. This approach addresses key limitations of traditional protocols, notably inefficient enzymatic cleavage and peptide overlap caused by the high abundance of basic residues in histones. Consequently, it significantly improves both modification site coverage and detection sensitivity.

Techniques like propionylation-paired isotope chemical labeling (PROPIC) enable quantitative histone PTM analysis from as few as 1,000 cells. This breakthrough facilitates epigenetic investigation of minute clinical specimens, such as tumor microdissections.

Analysis of Long Fragments and Combinatorial Modifications

Novel MS methods now target modification-rich histone terminal regions (e.g., H3 1-50) by analyzing intact long peptides. This capability reveals long-range combinatorial PTM patterns inaccessible to conventional short-peptide analysis. For instance, these methods have successfully identified co-existing H3K4 methylation with acetylation events, and even concurrent H3K4 and H3K27 methylation on the same molecule.

Such findings provide crucial molecular evidence for understanding complex regulatory mechanisms, governing bivalent chromatin domains.

Discovery and Validation of Novel Modifications

Non-classical acylations (e.g., succinylation, malonylation) have been confirmed through rigorous validation using synthetic peptide standards, HPLC co-elution studies, and isotopic labeling. Histone lysine succinylation (e.g., H3K122succ) has been identified across multiple model systems, including HeLa cells, mouse fibroblasts, Drosophila S2 cells, and yeast. Similarly, lysine malonylation has been documented in HeLa cells and yeast.

These modifications are structurally distinct from conventional acetylation, characterized by greater negative charge and steric hindrance, suggesting unique functional roles in epigenetic regulation.

Detection of lysine succinylation in core histones of different species (Xie Z et al., 2012)

Types and Functional Characteristics of Emerging Histone PTMs

The epigenetic landscape is far more complex than we once thought. A new class of novel histone PTMs is emerging beyond well-known marks like acetylation and methylation. These modifications are more than just additions; they are active regulators of gene expression with direct links to cellular metabolism, offering fresh angles for therapeutic intervention. For drug developers and researchers, understanding these novel histone modifications is key to unlocking the next generation of epigenetic therapeutics.

The following table summarizes the structural features, functional impacts, and key detection challenges for several representative novel modifications:

The Metabolic-Epigenetic Connection: Succinylation and Malonylation

These two modifications are particularly exciting for their role as a bridge between cell metabolism and gene regulation.

• Structural Attributes: Both succinylation and malonylation incorporate dicarboxylic acid moieties. These confer a stronger negative charge compared to the monocarboxylic group in acetylation, resulting in more pronounced disruption of nucleosome stability and DNA-histone interactions.
• Functional Mechanism: Empirical evidence indicates that succinylation at histone H3 lysine 122 (H3K122su) directly attenuates histone-DNA affinity. This facilitates chromatin decompaction and promotes transcriptional activation by effectively neutralizing the lysine residue's positive charge.
• Metabolic Coupling Significance: As key metabolic intermediates—succinyl-CoA from the tricarboxylic acid (TCA) cycle and malonyl-CoA from fatty acid synthesis—these modifications serve as crucial signaling conduits. They transmit information regarding cellular metabolic status to the chromatin landscape, thereby establishing a novel paradigm of "epimetabolic" coupling (Shi Y et al., 2021).

Unlocking the Next Layer of Epigenetic Control: Novel PTMs in Focus

The field of epigenetics extends far beyond standard acetylation and methylation. Novel histone modifications like crotonylation and 2-hydroxyisobutyrylation reveal unprecedented gene regulation mechanisms. Understanding these complex histone codes for drug discovery teams is critical for targeting diseases at their epigenetic root. These marks offer a new frontier for developing highly specific therapeutic interventions.

Spotlight on Key Novel Modifications

Two modifications stand out for their unique structures and roles:

• Crotonylation: This modification features a hydrophobic chain with an unsaturated double bond, which is specifically recognized by YEATS domain-containing proteins. It is highly abundant during spermatogenesis, particularly enriched on sex chromosome gene promoters. Its functional impact is distinct and non-interchangeable wit acetylation (Ji Y et al., 2025).
• 2-Hydroxyisobutyrylation: The modification's branched-chain structure imposes a unique steric conformation. It exhibits dynamic regulation during embryonic stem cell differentiation and is postulated to modulate developmental programs by recruiting of specific transcriptional coactivators like BRD4 (Zhang K et al., 2015).

The Combinatorial Power of the Histone Code

The true regulatory power of these PTMs emerges from their interactions.

• Combinatorial Coding: Novel and traditional post-translational modifications (PTMs) can co-occur on the same histone tail, creating a combinatorial code. For instance, H3K4 methylation frequently colocalizes with H3 acetylation at active promoters, while H3K27me3 and H3K9me3 collaboratively mark transcriptionally silent heterochromatin, such as the inactive X-chromosome.
• Collaborative Reader Recognition: The biological output of novel PTMs often depends on synergistic recognition by reader protein complexes. Multivalent readers (e.g., complexes harboring bromodomains, chromodomains, or PHD fingers) can bind simultaneously to multiple marks (e.g., H3K4me3 and H3K9cr). Furthermore, cross-talk occurs between adjacent modifications; for example, phosphorylation at H3S10 can inhibit the binding of methyl-reader proteins to the neighboring K9 residue (Andrews FH et al., 2016).

ADP-ribosylation: A Direct Link to DNA Repair Mechanisms

This critical PTM facilitates the DNA damage response through three clear mechanisms, making it a prime target for oncology research, particularly for PARP inhibitor development.

• Chromatin Decompaction: The negatively charged ADP-ribose moiety neutralizes positive charges on histone proteins. This electrostatic interference weakens histone-DNA interactions, resulting in a locally relaxed chromatin conformation that grants DNA repair machinery access to lesion sites.
• Repair Protein Recruitment: Poly-ADP-ribose (PAR) chains function as molecular "signal flags." These chains are specifically recognized and bound by specialized domains within repair proteins, such as XRCC1 and APTX. This direct recognition enables their rapid recruitment to damage locations, significantly accelerating the repair process.
• Dynamic, Damage-Dependent Response: The severity of DNA damage dictates the modification type. Mono-ADP-ribosylation (MARylation) is predominantly associated with mild damage, whereas severe DNA strand breaks trigger extensive PARylation. This switch to polymer formation amplifies the recruitment signal, orchestrating a robust and scalable repair response (Zha JJ et al., 2021).

Schematic representation of the histone mono-ADP-ribosylation reaction (Zha JJ et al., 2021)

Targeting Novel Histone Modifications: A New Frontier in Oncology Therapeutics

Aberrant epigenetic marks are well-established drivers of cancer, but emerging research into novel histone PTMs reveals even deeper mechanisms of disease. Understanding these pathways is no longer just academic; it provides actionable insights for oncology drug discovery. These modifications influence key cancer hallmarks, from metabolic reprogramming to immune evasion, offering new therapeutic targets for intervention.

1. Driving Tumor Growth Through Metabolic Rewiring

• Mechanism: In hepatocellular carcinoma (HCC), the elevated expression of catalytic enzyme HAT1 facilitates succinylation at histone H3 lysine 122 (H3K122succ). This modification neutralizes the lysine's positive charge, significantly attenuating histone-DNA binding affinity. The consequent reduction in nucleosomal stability induces a more decompacted and open chromatin conformation.
• Effects:
  • Oncogene Activation: Chromatin relaxation enables the transcriptional activation of downstream oncogenes (e.g., CREBBP, BPTF), directly fueling cellular proliferation and invasion.
  • Metabolic Reprogramming: This process particularly upregulates glycolysis-involved genes (e.g., PGAM1), markedly intensifying the Warburg effect. This preferential use of glycolysis despite oxygen availability generates ample ATP and biosynthetic precursors, thereby fulfilling the substantial metabolic demands of rapidly dividing cancer cells (Wang Z et al., 2025).

2. Helping Tumors Hide from the Immune System

• Mechanism: Acting as an acetyltransferase, KAT2A catalyzes H3K9 acetylation (H3K9ac) within the TGFB1 gene promoter, triggering the expression and secretion of TGF-β1.
• Effects:
  • Immune Response Suppression: Elevated TGF-β1 levels promote the expansion of immunosuppressive regulatory T cells (Tregs) within the tumor microenvironment and concurrently inhibit the cytotoxic activity of CD8+ T cells.
  • T Cell Exhaustion: TGF-β1 further induces CD8+ T cells to overexpress immune checkpoint molecules like PD-1, leading to their functional exhaustion and abrogating their killing capacity (Wang Z et al., 2025).

3. Accelerating Virus-Associated Liver Cancer

• Background: Chronic infection with hepatitis B virus (HBV) constitutes a major risk factor for HCC development.
• Mechanism: In this context, KAT2A demonstrates succinyltransferase activity. It associates with the metabolic enzyme α-KGDH, generating high local concentrations of succinyl-CoA near viral covalently closed circular DNA (cccDNA), which serves as the replication template for HBV. This localized succinyl-CoA pool subsequently drives the succinylation of histone H3 at lysine 79 (H3K79succ) on the cccDNA.
• Effect: H3K79succ enhances the transcriptional activity of HBV cccDNA by promoting a looser chromatin architecture, thereby accelerating viral replication and exacerbating chronic hepatitis and associated liver injury (Wang Z et al., 2025).

Novel HPTMs and their roles in HCC (Wang Z et al., 2025)

4. Chronic Respiratory Diseases: COPD and Lung Cancer

• Chronic Obstructive Pulmonary Disease (COPD): Investigations have identified 90 differentially modified lysine crotonylation (Kcr) sites on proteins in COPD patients experiencing respiratory failure. These specific Kcr-modified proteins hold promise as potential biomarkers for elucidating the molecular mechanisms underlying COPD pathogenesis.
• Non-Small-Cell Lung Carcinoma (NSCLC):
  • Crotonylation is a prevalent modification in NSCLC cells, with 2,696 identified sites across 1,024 proteins. A critical functional example is crotonylation at the K59 site (K59cr) of the BEX2 protein. This specific modification is indispensable for BEX2's role in promoting mitophagy. By facilitating the clearance of damaged mitochondria, K59cr enables cancer cells to evade pemetrexed-induced apoptosis, thereby conferring chemoresistance.
  • Therapeutic Implication: Targeting the BEX2 K59cr-mediated mitophagy pathway represents a novel strategic approach to counteract chemotherapy resistance in NSCLC, particularly when used in combination with established anticancer agents (Ji Y et al., 2025).

5. Cardiovascular Disease: The Protective Role of Crotonylation

• Mechanism of Action: In vascular smooth muscle cells (VSMCs), Kcr modifications are extensively present on proteins that are integral to cellular contraction, glycolytic metabolism, and the PI3K-Akt signaling pathway.
• Functional Implications: Protein crotonylation is linked to structural impairment, autophagy, and apoptosis in cardiac muscle cells. Specifically, crotonylation at specific residues (e.g., K199 on IDH3A, K2829 on TPM1) or administration of sodium crotonate (NaCr) can yield protective effects, including:
  • Suppression of pathological mitophagy and adverse cytoskeletal remodeling.
  • Attenuation of cardiomyocyte apoptosis.
  • Reduction of fibrotic processes and subsequent enhancement of cardiac function (Ji Y et al., 2025).

Biological functions of protein Kcr in diseases (Ji Y et al., 2025)

6. Metabolic Reprogramming in Oral Adenoid Cystic Carcinoma (OACC)

The progression of OACC is critically influenced by the epigenetic mark lysine 2-hydroxyisobutyrylation (Khib), which targets central glycolytic enzymes. Khib specifically modifies key residues, including K254 on GAPDH, K228 on ENO1, and K323 on PGK1.

These post-translational modifications markedly enhance enzymatic catalytic efficiency. By altering the steric conformation and electrostatic landscape of these proteins, Khib accelerates the overall flux of the glycolytic pathway.

This orchestrated enhancement drives profound metabolic reprogramming in OACC cells, resulting in a classic Warburg phenotype. Characterized by the preferential and rapid generation of ATP and macromolecular precursors through glycolysis, even in oxygen-replete conditions, this shift effectively meets the substantial bioenergetic and biosynthetic demands of incessant tumor proliferation.

Concurrently, the suppression of PDHA1—a pivotal subunit for mitochondrial function—further undermines oxidative phosphorylation. This impairment coerces cancer cells into a heightened dependency on the Khib-augmented glycolytic machinery, thereby cementing this malignant metabolic state.

Consequently, Khib is established as a pivotal epigenetic driver of OACC pathogenesis. Targeting the Khib modification pathway, for instance by inhibiting its specific modifying enzymes ("writers"), emerges as a promising and novel therapeutic strategy for this malignancy (Chen S et al., 2023).

The Khib of glycolysis pathway enzymes (Chen S et al., 2023)

Challenges and Future Directions

Despite accelerated advancements in novel post-translational modifications (PTMs), several fundamental questions persist:

• Identification of Enzymatic Machinery: The majority of "writer" and "eraser" enzymes responsible for novel PTMs remain uncharacterized. Their discovery necessitates integrated strategies employing activity-based chemical probes alongside substrate-mimetic peptide libraries for systematic mining.
• Ultra-Sensitive Detection Requirements: Achieving single-cell resolution for PTM analysis demands enhanced technological capabilities, particularly the integration of micro-pillar array column (μPAC) chromatography with targeted mass spectrometry (MS) methodologies.
• Dynamic Functional Analysis Bottleneck: A critical future objective involves developing time-resolved techniques, such as metabolic pulse-labeling for nascent histone synthesis, coupled with live-cell imaging. This combination is essential for real-time tracking of modification dynamics and turnover.

The discovery of these novel histone PTMs has profoundly expanded the complexity of the epigenetic regulatory landscape. Their intimate coupling with cellular metabolic networks and pivotal roles in disease pathogenesis unveils new avenues for precise epigenetic diagnostics and targeted therapeutics. Future investigations must focus on the integrative application of multi-omics technologies and chemical biology tools to systematically decipher the biological logic of this vast, uncharted epigenetic regulatory layer across molecular, cellular, and tissue levels.

The relationship between histone PTMs and cancer "Histone PTMs and Cancer: Beyond Classical Oncogenes".

To know the role of histone H 4 PTMs can be clicked "Histone H4 PTMs: Roles in DNA Repair and Genome Stability".

References

1. Zhang K, Li L, Zhu M, Wang G, Xie J, Zhao Y, Fan E, Xu L, Li E. Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities. J Proteomics. 2015 Jan 1;112:180-9.
2. Lin S, Garcia BA. Examining histone posttranslational modification patterns by high-resolution mass spectrometry. Methods Enzymol. 2012;512:3-28.
3. Bartke T, Borgel J, DiMaggio PA. Proteomics in epigenetics: new perspectives for cancer research. Brief Funct Genomics. 2013 May;12(3):205-18.
4. Noberini R, Savoia EO, Brandini S, Greco F, Marra F, Bertalot G, Pruneri G, McDonnell LA, Bonaldi T. Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples. Clin Epigenetics. 2021 Jul 28;13(1):145.
5. Taverna SD, Ueberheide BM, Liu Y, Tackett AJ, Diaz RL, Shabanowitz J, Chait BT, Hunt DF, Allis CD. Long-distance combinatorial linkage between methylation and acetylation on histone H3 N termini. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2086-91.
6. Xie Z, Dai J, Dai L, Tan M, Cheng Z, Wu Y, Boeke JD, Zhao Y. Lysine succinylation and lysine malonylation in histones. Mol Cell Proteomics. 2012 May;11(5):100-7.
7. Shi Y, Zhu J, Xu Y, Tang X, Yang Z, Huang A. Malonyl-proteome profiles of Staphylococcus aureus reveal lysine malonylation modification in enzymes involved in energy metabolism. Proteome Sci. 2021 Jan 12;19(1):1.
8. Mao M, Xue Y, He Y, Zhou X, Rafique F, Hu H, Liu J, Feng L, Yang W, Li X, Sun L, Huang Z, Ma J. Systematic identification and comparative analysis of lysine succinylation between the green and white parts of chimeric leaves of Ananas comosus var. bracteatus. BMC Genomics. 2020 Jun 3;21(1):383.
9. Ji Y, Liu S, Zhang Y, Min Y, Wei L, Guan C, Yu H, Zhang Z. Lysine crotonylation in disease: mechanisms, biological functions and therapeutic targets. Epigenetics Chromatin. 2025 Mar 22;18(1):13.
10. Andrews FH, Strahl BD, Kutateladze TG. Insights into newly discovered marks and readers of epigenetic information. Nat Chem Biol. 2016 Aug 18;12(9):662-8.
11. Wang Z, Liu Z, Lv M, Luan Z, Li T, Hu J. Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation. Clin Epigenetics. 2025 Feb 20;17(1):30.
12. Chen S, Li D, Zeng Z, Zhang W, Xie H, Tang J, Liao S, Cai W, Liu F, Tang D, Dai Y. Analysis of proteome and post-translational modifications of 2-hydroxyisobutyrylation reveals the glycolysis pathway in oral adenoid cystic carcinoma. World J Surg Oncol. 2023 Sep 23;21(1):301.
13. Zha JJ, Tang Y, Wang YL. Role of mono-ADP-ribosylation histone modification (Review). Exp Ther Med. 2021 Jun;21(6):577.